179 related articles for article (PubMed ID: 33405336)
1. Brain Morphological Alterations Are Detected in Early-Stage Parkinson's Disease with MRI Morphometry.
Fu T; Klietz M; Nösel P; Wegner F; Schrader C; Höglinger GU; Dadak M; Mahmoudi N; Lanfermann H; Ding XQ
J Neuroimaging; 2020 Nov; 30(6):786-792. PubMed ID: 33405336
[TBL] [Abstract][Full Text] [Related]
2. Clinically Applicable Quantitative Magnetic Resonance Morphologic Measurements of Grey Matter Changes in the Human Brain.
Fu T; Kobeleva X; Bronzlik P; Nösel P; Dadak M; Lanfermann H; Petri S; Ding XQ
Brain Sci; 2021 Jan; 11(1):. PubMed ID: 33466559
[TBL] [Abstract][Full Text] [Related]
3. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Sulcal depth and cortical thickness in Parkinson's disease.
Wang E; Jia Y; Ya Y; Xu J; Mao C; Luo W; Fan G; Jiang Z
Brain Imaging Behav; 2021 Oct; 15(5):2340-2346. PubMed ID: 34018166
[TBL] [Abstract][Full Text] [Related]
5. Considering total intracranial volume and other nuisance variables in brain voxel based morphometry in idiopathic PD.
Crowley S; Huang H; Tanner J; Zhao Q; Schwab NA; Hizel L; Ramon D; Brumback B; Ding M; Price CC
Brain Imaging Behav; 2018 Feb; 12(1):1-12. PubMed ID: 28070745
[TBL] [Abstract][Full Text] [Related]
6. Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study.
Cui X; Li L; Yu L; Xing H; Chang H; Zhao L; Qian J; Song Q; Zhou S; Dong C
Clinics (Sao Paulo); 2020; 75():e1505. PubMed ID: 32555945
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
8. Cortical Thickness Estimations of FreeSurfer and the CAT12 Toolbox in Patients with Alzheimer's Disease and Healthy Controls.
Seiger R; Ganger S; Kranz GS; Hahn A; Lanzenberger R
J Neuroimaging; 2018 Sep; 28(5):515-523. PubMed ID: 29766613
[TBL] [Abstract][Full Text] [Related]
9. Grey matter abnormalities in Parkinson's disease: a voxel-wise meta-analysis.
Xu X; Han Q; Lin J; Wang L; Wu F; Shang H
Eur J Neurol; 2020 Apr; 27(4):653-659. PubMed ID: 31770481
[TBL] [Abstract][Full Text] [Related]
10. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
Xu Y; Yang J; Hu X; Shang H
J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
[TBL] [Abstract][Full Text] [Related]
11. Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.
Martinez-Horta S; Sampedro F; Pagonabarraga J; Fernandez-Bobadilla R; Marin-Lahoz J; Riba J; Kulisevsky J
Brain Imaging Behav; 2017 Oct; 11(5):1334-1342. PubMed ID: 27730477
[TBL] [Abstract][Full Text] [Related]
12. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
13. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
Pezzoli S; Cagnin A; Antonini A; Venneri A
Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
[No Abstract] [Full Text] [Related]
14. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
[TBL] [Abstract][Full Text] [Related]
15. Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.
Li R; Zou T; Wang X; Wang H; Hu X; Xie F; Meng L; Chen H
Hum Brain Mapp; 2022 Feb; 43(3):1145-1156. PubMed ID: 34792836
[TBL] [Abstract][Full Text] [Related]
16. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.
Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T
J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896
[TBL] [Abstract][Full Text] [Related]
17. Voxel-based morphometry of grey matter structures in Parkinson's Disease with wearing-off.
Zhai H; Fan W; Xiao Y; Zhu Z; Ding Y; He C; Zhang W; Xu Y; Zhang Y
Brain Imaging Behav; 2023 Dec; 17(6):725-737. PubMed ID: 37735325
[TBL] [Abstract][Full Text] [Related]
18. Correlations between dopamine transporter density measured by
Maekawa T; Sato N; Ota M; Sugiyama A; Sone D; Enokizono M; Kimura Y; Mukai Y; Murata M; Takano H; Imabayashi E; Matsuda H; Kunimatsu A; Abe O
Jpn J Radiol; 2017 Dec; 35(12):755-759. PubMed ID: 29063467
[TBL] [Abstract][Full Text] [Related]
19. Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
Lee HM; Kwon KY; Kim MJ; Jang JW; Suh SI; Koh SB; Kim JH
Parkinsonism Relat Disord; 2014 Jun; 20(6):622-6. PubMed ID: 24703894
[TBL] [Abstract][Full Text] [Related]
20. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
